CPC A61K 9/0029 (2013.01) [A23L 33/115 (2016.08); A23L 33/16 (2016.08); A23L 33/175 (2016.08); A61J 1/2093 (2013.01); A61K 9/107 (2013.01); A61K 35/57 (2013.01); A61K 36/48 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/183 (2013.01); A61K 47/20 (2013.01); A61K 47/22 (2013.01); A23V 2002/00 (2013.01)] | 6 Claims |
1. An infusion preparation comprising two chambers separated by a communicably openable partition,
a first chamber containing a first-chamber infusion comprising a fat emulsion and further comprising at least one member selected from the group consisting of amino acids that have a buffer action, divalent organic acids, and trivalent organic acids,
a second chamber containing a second-chamber infusion comprising an amino acid and at least calcium as an electrolyte, wherein
a total concentration of the amino acids that have a buffer action, divalent organic acids, and trivalent organic acids in the first-chamber infusion is 0.15 to 0.5 g/L, and
a mixture of the first- and second-chamber infusions has a pH of 6.53 or less as measured 48 hours after the partition is communicably opened.
|